BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19672247)

  • 1. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs.
    Liu YP; von Eije KJ; Schopman NC; Westerink JT; ter Brake O; Haasnoot J; Berkhout B
    Mol Ther; 2009 Oct; 17(10):1712-23. PubMed ID: 19672247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of extended short hairpin RNAs for HIV-1 inhibition.
    Liu YP; Haasnoot J; Berkhout B
    Nucleic Acids Res; 2007; 35(17):5683-93. PubMed ID: 17715143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat.
    Barichievy S; Saayman S; von Eije KJ; Morris KV; Arbuthnot P; Weinberg MS
    Oligonucleotides; 2007; 17(4):419-31. PubMed ID: 17896874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA.
    Saayman S; Barichievy S; Capovilla A; Morris KV; Arbuthnot P; Weinberg MS
    PLoS One; 2008 Jul; 3(7):e2602. PubMed ID: 18596982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.
    Herrera-Carrillo E; Liu YP; Berkhout B
    Mol Ther; 2014 Mar; 22(3):596-606. PubMed ID: 24336172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells.
    Nishitsuji H; Ikeda T; Miyoshi H; Ohashi T; Kannagi M; Masuda T
    Microbes Infect; 2004 Jan; 6(1):76-85. PubMed ID: 14738896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ; ter Brake O; Berkhout B
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of lentivirally expressed siRNAs.
    Liu YP; Berkhout B
    Methods Mol Biol; 2013; 942():233-57. PubMed ID: 23027055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-inhibition of HIV-1 by a long hairpin RNA expressed within the viral genome.
    Konstantinova P; ter Brake O; Haasnoot J; de Haan P; Berkhout B
    Retrovirology; 2007 Mar; 4():15. PubMed ID: 17331227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration.
    Nishitsuji H; Kohara M; Kannagi M; Masuda T
    J Virol; 2006 Aug; 80(15):7658-66. PubMed ID: 16840344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of long anti-HIV-1 hairpin RNAs for the generation of multiple siRNAs: advantages and limitations.
    Sano M; Li H; Nakanishi M; Rossi JJ
    Mol Ther; 2008 Jan; 16(1):170-7. PubMed ID: 17726454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.
    ter Brake O; 't Hooft K; Liu YP; Centlivre M; von Eije KJ; Berkhout B
    Mol Ther; 2008 Mar; 16(3):557-64. PubMed ID: 18180777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.
    Das AT; Brummelkamp TR; Westerhout EM; Vink M; Madiredjo M; Bernards R; Berkhout B
    J Virol; 2004 Mar; 78(5):2601-5. PubMed ID: 14963165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA.
    Konstantinova P; de Vries W; Haasnoot J; ter Brake O; de Haan P; Berkhout B
    Gene Ther; 2006 Oct; 13(19):1403-13. PubMed ID: 16708080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 escape from RNA interference.
    Boden D; Pusch O; Lee F; Tucker L; Ramratnam B
    J Virol; 2003 Nov; 77(21):11531-5. PubMed ID: 14557638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
    Berkhout B; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
    Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
    Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.